Omeros Corporation Is A Biopharmaceutical Company Based In Seattlewashingtonfounded In 1994 By Drgregory Ademopulosthe Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Omeromeros Is Dedicated To Discoveringdevelopingand Commercializing Small Molecule And Protein Therapeuticswith A Focus On Inflammationcomplement Mediated Diseasesand Central Nervous System Disorders One Of Omeroskey Products Is Omidriaan Approved Ophthalmic Drug Used During Cataract Surgery To Maintain Pupil Size And Reduce Postoperative Painthe Company Is Also Developing Narsoplimaban Investigational Monoclonal Antibody Targeting Masp 2 For Various Orphan Indicationsomeros Has A Robust Pipeline That Includes Investigational Programs Targeting Novel Pathways Within The Complement System And Gpcr Targetsas Well As An Anti Infective Therapeutic Platform Called Targeted Complement Activation Therapyt Cat With A Strong Emphasis On Research And Developmentomeros Is Committed To Advancing Its Innovative Therapies To Benefit Patients
No conferences found for this company.
| Company Name | Omeros Corporation |
| Country |
United States
|
| Address | 201 Elliott Avenue West Seattle Wa 98119 United States |
| Telephone | Login to View |
| Login to View |
